Healing of chronic necrobiosis lipoidica lesions in a Type 1 diabetic patient after pancreas-kidney transplantation: A case report

Journal of Endocrinological Investigation

Volumn 30, Issue 3, 2007, Pages 259-262

  Gullo, D ^a   Latina, A ^a   Tomaselli, L ^a   Arpi, M L ^a   Squatrito, S ^a   Curatolo, S ^b   La Greca, S ^b   Vigneri, R ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b GARIBALDI HOSPITAL   (Italy)

Author keywords

Necrobiosis lipoidica treatment

Indexed keywords

CORTICOSTEROID; INSULIN; KETOROLAC; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NICOTINAMIDE; OXYGEN; PENTOXIFYLLINE; PREDNISONE; TACROLIMUS;

ADULT; ARTICLE; CASE REPORT; CHRONIC DISEASE; CONTINUOUS INFUSION; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DRUG TREATMENT FAILURE; GRAFT REJECTION; HEALING; HISTIOCYTE; HUMAN; HUMAN TISSUE; HYPERBARIC OXYGEN; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FAILURE; KIDNEY PANCREAS TRANSPLANTATION; LYMPHOCYTE; MALE; METABOLIC REGULATION; MICROCIRCULATION; NECROBIOSIS LIPOIDICA; OXYGEN THERAPY; REMISSION; SCAR FORMATION; SKIN BIOPSY; SKIN BLOOD FLOW; SKIN INFLAMMATION;

EID: 34250646196     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03347436     Document Type: Article

References (23)

1. Muller SA, Winkelmann RK. Necrobiosis lipoidica diabeticorum. A clinical and pathological investigation of 171 cases. Arch Dermatol 1966, 93: 272-81.
2. Imtiaz KE, Khaleeli AA. Squamous cell carcinoma developing in necrobiosis lipoidica. Diabet Med 2001, 18: 325-8.
3. Alegre VA, Winkelmann RK. A new histopathologic feature of necrobiosis lipoidica diabeticorum: lymphoid nodules. J Cutan Pathol 1988, 15: 75-7.
4. Kelly WF, Nicholas J, Adams J, Mahmood R. Necrobiosis lipoidica diabeticorum: association with background retinopathy, smoking, and proteinuria. A case controlled study. Diabet Med 1993, 10: 725-8.
5. Cohen O, Yaniv R, Karasik A, Trau H. Necrobiosis lipoidica and diabetic control revisited. Med Hypotheses 1996, 46: 348-50.
6. Tidman M J, Duncan C. The treatment of necrobiosis lipoidica. Br J Diabetes Vasc Dis 2005, 5: 37-41.
7. O'Toole EA, Kennedy U, Nolan JJ, Young MM, Rogers S, Barnes L. Necrobiosis lipoidica: only a minority of patients have diabetes mellitus. Br J Dermatol 1999, 140: 283-6.
8. Ullman S, Dahl MV. Necrobiosis lipoidica. An immunofluorescence study. Arch Dermatol 1977, 113: 1671-3.
9. Noz KC, Korstanje MJ, Vermeer BJ. Ulcerating necrobiosis lipoidica effectively treated with pentoxifylline. Clin Exp Dermatol 1993, 18: 78-9.
10. Sawada Y. Successful treatment of ulcerated necrobiosis: lipoidica diabeticorum with prostaglandin E1 and skin flap transfer - a case report. J Dermatol 1985, 12: 449-54.
11. Harth W, Linse R. Topical tacrolimus in granuloma annulare and necrobiosis lipoidica. Br J Dermatol 2004, 150: 792-4.
12. Clayton TH, Harrison PV. Successful treatment of chronic ulcerated necrobiosis lipoidica with 0.1% topical tacrolimus ointment. Br J Dermatol 2005, 152: 581-2.
13. Reinhard G, Lohmann F, Uerlich M, Bauer R, Bieber T. Successful treatment of ulcerated necrobiosis lipoidica with mycophenolate mofetil. Acta Derm Venereol 2000, 80: 312-3.
14. Petzelbauer P, Wolff K, Tappeiner G. Necrobiosis lipoidica: treatment with systemic corticosteroids. Br J Dermatol 1992, 126: 542-5.
15. Taniguchi Y, Sakamoto T, Shimizu M. A case of necrobiosis lipoidica treated with systemic corticosteroid. J Dermatol 1993, 20: 304-7.
16. Hocqueloux L, Gautier JF, Lebbe C, et al. Ulcerated necrobiosis lipoidica associated with insulin-dependent diabetes mellitus. Beneficial effect of corticosteroid therapy by oral administration. Presse Med 1996, 25: 25-7.
17. Stride A, Lambert P, Burden ACF, Mansell P, Page S, Hattersley AT. Necrobiosis lipodica is a clinical feature of Maturity-Onset Diabetes of the Young. Diabetes Care 2002, 25: 1249-50.
18. Abendroth D, Schmand J, Landgraf R, Illner WD, Land W. Diabetic microangiopathy in type 1 (insulin-dependent) diabetic patients after successful pancreatic and kidney or solitary kidney transplantation. Diabetologia 1991, 34 Suppl 1: S131-4.
19. Eberl N, Piehlmeier W, Dachauer S, Konig A, Land W, Landgraf R. Blood flow in the skin of type 1 diabetic patients before and after combined pancreas/kidney transplantation. Diabetes Metab Res Rev 2005, 21: 525-32.
20. Ngo BT, Hayes KD, DiMiao DJ, Srinivasan SK, Huerter CJ, Rendell MS. Manifestations of cutaneous diabetic microangiopathy. Am J Clin Dermatol 2005, 6: 225-37.
21. Fiorina P, Folli F, Bertuzzi F, et al. Long-term beneficial effect of islet transplantation on diabetic macro-/microangiopathy in type 1 diabetic kidney-transplanted patients. Diabetes Care 2003, 26: 1129-36.
22. Gillard P, Ling Z, Lannoo M, et al. Beta-cell transplantation restores metabolic control and quality of life in a patient with subcutaneous insulin resistance. Diabetes Care 2004, 27: 2243-4.
23. Ryan EA, Lakey JRT, Rajotte RV, et al. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes 2001, 50: 710-9.